MYLAN 711 (Hydrochlorothiazide and methyldopa 25 mg / 250 mg)
Pill imprint MYLAN 711 has been identified as Hydrochlorothiazide and methyldopa 25 mg / 250 mg.
Hydrochlorothiazide/methyldopa is used in the treatment of high blood pressure and belongs to the drug class antihypertensive combinations. Risk cannot be ruled out during pregnancy. Hydrochlorothiazide/methyldopa 25 mg / 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for MYLAN 711 (Hydrochlorothiazide and methyldopa 25 mg / 250 mg)
- 25 mg / 250 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antihypertensive combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Yellow No. 6
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|49999-0082||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
Hydrochlorothiazide and methyldopa is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...